We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CHHMF market cap is 0. The company's latest EPS is DKK and P/E is N/A.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 214.1M | 281.13M | 428.39M | 444.4M | 407.87M |
| Operating Income | 77.18M | 116.85M | 202.77M | 230.64M | 168.96M |
| Net Income | 59.16M | 88.35M | 159.47M | 178.67M | 136.28M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 263.12M | 344.91M | 501.27M | 657.98M | 676.67M |
| Total Liabilities | 60.37M | 79.93M | 144.07M | 124.93M | 111.36M |
| Total Equity | 202.75M | 264.98M | 357.21M | 533.04M | 565.32M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 72.02M | 107.9M | 176.86M | 154.15M | 129M |
| Investing | -26.61M | -24.68M | -56.05M | -40.83M | -43.49M |
| Financing | -46.26M | -26.04M | -69.01M | -2.93M | -105.72M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 17.4M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 550.4 (100%) |
| Company Name | Chemotec AS (PK) |
| Address |
gydevang 43 allerod 3450 |
| Website | https://www.chemometec.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
